BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25651433)

  • 1. A review of the management of positive biochemical screening for phaeochromocytoma and paraganglioma: a salutary tale.
    Garrahy A; Casey R; Wall D; Bell M; O'Shea PM
    Int J Clin Pract; 2015 Jul; 69(7):802-9. PubMed ID: 25651433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological diagnosis of pheochromocytomas and paragangliomas].
    d'Herbomez M; Rouaix N; Bauters C; Wémeau JL
    Presse Med; 2009 Jun; 38(6):927-34. PubMed ID: 19135846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
    van Berkel A; Lenders JW; Timmers HJ
    Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phaeochromocytoma: diagnostic challenges for biochemical screening and diagnosis.
    Barron J
    J Clin Pathol; 2010 Aug; 63(8):669-74. PubMed ID: 20547690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical detection of phaeochromocytoma: why are we continuing to ignore the evidence?
    Peaston RT; Ball S
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):6-10. PubMed ID: 18275668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma.
    Samsudin I; Page MM; Hoad K; Chubb P; Gillett M; Glendenning P; Vasikaran S
    Ann Clin Biochem; 2018 Nov; 55(6):679-684. PubMed ID: 29660998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MANAGEMENT OF CATECHOLAMINE-SECRETING TUMORS IN PREGNANCY: A REVIEW.
    Prete A; Paragliola RM; Salvatori R; Corsello SM
    Endocr Pract; 2016 Mar; 22(3):357-70. PubMed ID: 26536138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adrenal tumours in childhood].
    Martos-Moreno GA; Pozo-Román J; Argente J
    An Pediatr (Barc); 2013 Sep; 79(3):187.e1-187.e16. PubMed ID: 23796614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
    Schreiner F; Beuschlein F
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101347. PubMed ID: 31662271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological diagnosis of pheochromocytoma in 2014].
    Rouaix-Emery N; Tierny-Fontalirand C; Cardot-Bauters C; Carnaille B; Wemeau JL; d'Herbomez M
    Ann Biol Clin (Paris); 2014; 72(1):7-13. PubMed ID: 24492094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
    Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
    PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pheochromocytoma and paraganglioma].
    Gimenez-Roqueplo AP
    Rev Prat; 2015 Jun; 65(6):826-30. PubMed ID: 26298909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
    Srirangalingam U; Walker L; Khoo B; MacDonald F; Gardner D; Wilkin TJ; Skelly RH; George E; Spooner D; Monson JP; Grossman AB; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):587-96. PubMed ID: 18419787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
    Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
    Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma.
    Boot CS
    Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
    Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
    Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A probabilistic assessment of the diagnosis of paraganglioma/pheochromocytoma based on clinical criteria and biochemical/imaging findings.
    Ilias I; Meristoudis G; Notopoulos A
    Hell J Nucl Med; 2015; 18(1):63-5. PubMed ID: 25840574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consideration of the degree of increase in urine metadrenalines provides superior specificity in the diagnosis of phaeochromocytoma than additional urine catecholamine measurement.
    Scargill JJ; Reed P; Kane J
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):73-5. PubMed ID: 23417444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pheochromocytoma--rare and often undiagnosed condition].
    Manhem P; Wahrenberg H
    Lakartidningen; 2002 Mar; 99(14):1585-9. PubMed ID: 12025214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.